Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 7014-7021

  Ihnát, Peter ^a,b   Vávra, Petr ^a,b   Zonča, Pavel ^a,b  

^a UNIVERSITY OF OSTRAVA   (Czech Republic)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Colorectal cancer; Liver first approach; Reverse strategy; Simultaneous resection; Up front hepatectomy

Indexed keywords

ANTINEOPLASTIC AGENT; IRINOTECAN; OXALIPLATIN; FLUOROURACIL; FOLINIC ACID;

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CARCINOMA; HUMAN; LIVER METASTASIS; LIVER RESECTION; LONG TERM SURVIVAL; MORBIDITY; MULTIMODALITY CANCER THERAPY; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PATIENT CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYNCHRONOUS LIVER METASTASIS; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; CARCINOMA; COLON RESECTION; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION; LIVER NEOPLASMS; MORTALITY; NEOADJUVANT THERAPY; PATHOLOGY; PATIENT SELECTION; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CLINICAL TRIAL (TOPIC); COLORECTAL LIVER METASTASIS; COLORECTAL SURGERY; EVIDENCE BASED MEDICINE; FATTY LIVER; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; SURGICAL APPROACH; SURVIVAL TIME; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930829067     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.7014     Document Type: Review

References (44)

1. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007; 16: 3-5 [PMID: 17493802]
2. Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, Lee PH. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007; 14: 786-794 [PMID: 17103254]
3. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, Morel P, Rubbia-Brandt L, Majno PE. 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008; 25: 430-435 [PMID: 19212115 DOI: 10.1159/000184734]
4. De Rosa A, Gomez D, Brooks A, Cameron IC. "Liver-first" approach for synchronous colorectal liver metastases: is this a justifiable approach? J Hepatobiliary Pancreat Sci 2013; 20: 263-270 [PMID: 23325126 DOI: 10.1007/s00534-012-0583-x]
5. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006; 244: 254-259 [PMID: 16858188]
6. Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 2009; 4: 56-62 [PMID: 19149763]
7. Giuliante F, Ardito F, Vellone M, Ranucci G, Federico B, Giovannini I, Nuzzo G. Role of the surgeon as a variable in longterm survival after liver resection for colorectal metastases. J Surg Oncol 2009; 100: 538-545 [PMID: 19722234 DOI: 10.1002/ jso.21393]
8. Ito H, Are C, Gonen M, D'Angelica M, Dematteo RP, Kemeny NE, Fong Y, Blumgart LH, Jarnagin WR. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247: 994-1002 [PMID: 18520227 DOI: 10.1097/SLA.0b013e31816c405f]
9. Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP, Prasad KR. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg 2010; 251: 91-100 [PMID: 19858702 DOI: 10.1097/SLA.0b013e3181bfda3c]
10. Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, Gerstel E, Roth A, Majno PE, Mentha G. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012; 256: 772-778; discussion 778-779 [PMID: 23095621 DOI: 10.1097/SLA.0b013e3182734423]
11. Straka M, Skrovina M, Soumarova R, Kotasek R, Burda L, Vojtek C. Up front hepatectomy for metastatic rectal carcinoma-reversed, liver first approach. Early experience with 15 patients. Neoplasma 2014; 61: 447-452 [PMID: 25027742]
12. Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010; 210: 934-941 [PMID: 20510802 DOI: 10.1016/j.jamcollsurg.2010.02.039]
13. Fahy BN, Fischer CP. Synchronous resection of colorectal primary and hepatic metastasis. J Gastrointest Oncol 2012; 3: 48-58 [PMID: 22811869 DOI: 10.3978/j.issn.2078-6891.2012.004]
14. Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg 2011; 3: 183-196 [PMID: 22224173 DOI: 10.4240/wjgs.v3.i12.183]
15. de Haas RJ, Adam R, Wicherts DA, Azoulay D, Bismuth H, Vibert E, Salloum C, Perdigao F, Benkabbou A, Castaing D. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 2010; 97: 1279-1289 [PMID: 20578183 DOI: 10.1002/bjs.7106]
16. Tsoulfas G, Pramateftakis MG. Management of rectal cancer and liver metastatic disease: which comes first? Int J Surg Oncol 2012; 2012: 196908 [PMID: 22778934 DOI: 10.1155/2012/196908]
17. Jegatheeswaran S, Mason JM, Hancock HC, Siriwardena AK. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg 2013; 148: 385-391 [PMID: 23715907 DOI: 10.1001/ jamasurg.2013.1216]
18. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012; 255: 237-247 [PMID: 22041509 DOI: 10.1097/SLA.0b013e3182356236]
19. Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006; 24: 3939-3945 [PMID: 16921046]
20. Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LK, Wong WD, Paty PB. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009; 27: 3379-3384 [PMID: 19487380 DOI: 10.1200/JCO.2008.20.9817]
21. Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835 [PMID: 18662955 DOI: 10.1093/annonc/mdn398]
22. Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012; 17: 1225-1239 [PMID: 22962059 DOI: 10.1634/theoncologist.2012-0121]
23. Lykoudis PM, O'Reilly D, Nastos K, Fusai G. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg 2014; 101: 605-612 [PMID: 24652674 DOI: 10.1002/ bjs.9449]
24. Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH. The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009; 52: 23-30 [PMID: 19273952 DOI: 10.1007/ DCR.0b013e318197939a]
25. de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, Dejong C.H. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford) 2011; 13: 745-752 [PMID: 21929676 DOI: 10.1111/j.1477-2574.2011.00372.x]
26. Grundmann RT, Hermanek P, Merkel S, Germer CT, Grundmann RT, Hauss J, Henne-Bruns D, Herfarth K, Hermanek P, Hopt UT, Junginger T, Klar E, Klempnauer J, Knapp WH, Kraus M, Lang H, Link KH, Löhe F, Merkel S, Oldhafer KJ, Raab HR, Rau HG, Reinacher-Schick A, Ricke J, Roder J, Schäfer AO, Schlitt HJ, Schön MR, Stippel D, Tannapfel A, Tatsch K, Vogl TJ. [Diagnosis and treatment of colorectal liver metastases-workflow]. Zentralbl Chir 2008; 133: 267-284 [PMID: 18563694 DOI: 10.1055/ s-2008-1076796]
27. Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010; 107: 335-342 [PMID: 20532128 DOI: 10.3238/arztebl.2010.0335]
28. Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20: 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391]
29. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016 [PMID: 18358928 DOI: 10.1016/ S0140-6736(08)60455-9]
30. Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 2008; 34: 609-614 [PMID: 17764887]
31. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286 [PMID: 17315288]
32. Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapyinduced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009; 16: 137-144 [PMID: 19093069 DOI: 10.1007/s00534-008-0016-z]
33. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, Rougier P, Nordlinger B. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7 [PMID: 16371728]
34. Mentha G, Terraz S, Morel P, Andres A, Giostra E, Roth A, Rubbia-Brandt L, Majno P. Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases. Br J Surg 2009; 96: 95-103 [PMID: 19109800 DOI: 10.1002/bjs.6436]
35. Tanaka K, Takakura H, Takeda K, Matsuo K, Nagano Y, Endo I. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg 2009; 250: 935-942 [PMID: 19953712]
36. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, Ducreux M, Azoulay D, Bismuth H, Castaing D. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009; 27: 1829-1835 [PMID: 19273699 DOI: 10.1200/JCO.2008.19.9273]
37. Stein A, Schmoll HJ. Systemic treatment of liver metastases from colorectal cancer. Ther Adv Med Oncol 2013; 5: 193-203 [PMID: 23634197 DOI: 10.1177/1758834012473347]
38. Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet JF, Laurent C, Cugat E, Colombo PE, Milicevic M. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 2010; 252: 774-787 [PMID: 21037433 DOI: 10.1097/ SLA.0b013e3181fcf3e3]
39. Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA, White RR, Clary BM. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multiinstitutional analysis. Ann Surg Oncol 2009; 16: 1809-1819 [PMID: 18979139 DOI: 10.1245/s10434-008-0181-y]
40. Lubezky N, Geva R, Shmueli E, Nakache R, Klausner JM, Figer A, Ben-Haim M. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg 2009; 33: 1028-1034 [PMID: 19234865 DOI: 10.1007/s00268-009-9945-1]
41. Zhu D, Zhong Y, Wei Y, Ye L, Lin Q, Ren L, Ye Q, Liu T, Xu J, Qin X. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014; 9: e86543 [PMID: 24466143 DOI: 10.1371/journal.pone.0086543]
42. Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H, Grieg P, McGilvary I, Taylor B, Wei A, Moulton CA, Gallinger S. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol 2013; 20: 295-304 [PMID: 23054102 DOI: 10.1245/s10434-012-2424-1]
43. Wieser M, Sauerland S, Arnold D, Schmiegel W, Reinacher-Schick A. Peri-operative chemotherapy for the treatment ofresectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. BMC Cancer 2010; 10: 309 [PMID: 20565923 DOI: 10.1186/1471-2407-10-309]
44. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 2010; 17: 492-501 [PMID: 19856028 DOI: 10.1245/s10434-009-0781-1]